möglich sobald bei der ZB eingereicht worden ist.
694. Investigating the potential of psilocybin for compulsive eating in a rat model of binge eating.
Int. J. Neuropsychopharmacol. 28, ii55 - ii56 (2025)
BackgroundBinge
eating disorder (BED) is the most prevalent eating disorder, often
associated with metabolic syndrome and other mental health
comorbidities. Despite its impact, current treatment options remain
limited. BED is associated with compulsive intake of foods typically
high in fat and sugar, as well as neuroplastic changes in brain regions
such as the nucleus accumbens, dorsal striatum, and prefrontal cortex.
Psilocybin, a psychedelic compound, has been shown to promote
neuroplasticity and may offer a novel intervention for compulsive
eating.Aims & ObjectivesThis
study aimed to assess whether psilocybin reduces compulsive eating in a
preclinical rodent model of BED. We hypothesised that psilocybin would
reduce compulsive-like eating in our rat model.Method44
female rats were divided into four groups: Control + Saline, Control +
Psilocybin, Binge + Saline, and Binge + Psilocybin. Binge groups
received intermittent access to a high-fat/high-sugar (HFHS) diet 3x
p/week for 1 hour for 10 weeks. Control rats received standard chow
only. Compulsive eating was assessed using a conditioned suppression
paradigm which involved assessment of eating of HFHS at baseline and
then after 4 conditioning sessions. Psilocybin (2 mg/kg, i.p.) or saline
was administered prior to the start of baseline acclimation sessions
and again immediately after the 4th conditioning session (approx. 24
hours before test). Baseline sessions (30min) occurred over 12 days
where rats were placed in fear-conditioning chambers with access to food
(HFHS for binge groups, chow for controls). All rats then underwent
conditioning (4 x 30min daily session) where a light cue was paired with
a 0.5 mA foot shock. On test day, the latency to start eating in the
presence of the cue was assessed as a measured of compulsive-like
behaviour towards HFHS.ResultsPsilocybin
at the dose tested did not impact latency to start eating or food
intake on test day, but potentially affected freezing behaviour
(analysis is ongoing).Discussion & ConclusionsWhile
psilocybin did not significantly reduce compulsive eating at the tested
dose, its potential effects on fear conditioning may reflect modulation
of learning and memory circuits. Ongoing molecular analyses will
further explore the possible underlying neurobiological mechanisms.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Meeting abstract
Schlagwörter
Psilocybin ; Binge Eating ; Binge-eating Disorder
ISSN (print) / ISBN
1461-1457
e-ISSN
1469-5111
Zeitschrift
International Journal of Neuropsychopharmacology
Quellenangaben
Band: 28,
Heft: Supplement_2,
Seiten: ii55 - ii56
Verlag
Oxford University Press
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Computational Biology (ICB)